Aktieanalys

Annexin: Directed Issue confirms focus on Cancer - Redeye

{newsItem.title}

Redeye Publicerad: 20 Dec 2022 08:50

Redeye gives a short comment on today’s news of a directed issue in Annexin, where the proceeds will be used to initiate a focus within cancer.

Länk till analysen i sin helhet: https://www.redeye.se/research/869396/annexin-directed-issue-confirms-focus-on-cancer?utm_source=finwire&utm_medium=RSS

Nyheter om Annexin

Läses av andra just nu

Om aktien Annexin

Senaste nytt